Usana Health Sciences, Inc. (USNA) fundamentals score
USANA Health Sciences, Inc. develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold throughout the world. In 2025, it generateds $925 million in net sales and finished the year with approximately 387,000 active Customers in its core nutritional business.
Medicinal Chemicals & Botanical Products · Healthcare · Listed on NYSE
Overall: 5.1 out of 10, Mixed fundamentals
- Growth: 2.2/10
- Profitability: 3.1/10
- Financial health: 7.1/10
- Earnings quality: 8.8/10
- Valuation: 6.7/10
Scores are calculated from Usana Health Sciences, Inc.’s SEC filings, using the 12 months through 2026-07. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10